NVAXNOVAVAX INC

Nasdaq novavax.com


$ 4.48 $ -0.14 (-3.04 %)    

Wednesday, 08-May-2024 15:59:55 EDT
QQQ $ 439.55 $ -0.26 (-0.06 %)
DIA $ 390.50 $ 1.74 (0.45 %)
SPY $ 517.10 $ 0.05 (0.01 %)
TLT $ 90.18 $ -0.55 (-0.61 %)
GLD $ 213.58 $ -0.63 (-0.29 %)
$ 4.47
$ 4.54
$ 0.00 x 0
$ 0.00 x 0
$ 4.43 - $ 4.55
$ 3.53 - $ 11.36
3,073,890
na
450.43M
$ 0.46
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-28-2024 12-31-2023 10-K
2 11-09-2023 09-30-2023 10-Q
3 08-08-2023 06-30-2023 10-Q
4 05-09-2023 03-31-2023 10-Q
5 02-28-2023 12-31-2022 10-K
6 11-09-2022 09-30-2022 10-Q
7 08-08-2022 06-30-2022 10-Q
8 05-09-2022 03-31-2022 10-Q
9 03-01-2022 12-31-2021 10-K
10 11-04-2021 09-30-2021 10-Q
11 08-05-2021 06-30-2021 10-Q
12 05-10-2021 03-31-2021 10-Q
13 03-01-2021 12-31-2020 10-K
14 11-10-2020 09-30-2020 10-Q
15 08-10-2020 06-30-2020 10-Q
16 05-11-2020 03-31-2020 10-Q
17 03-11-2020 12-31-2019 10-K
18 11-07-2019 09-30-2019 10-Q
19 08-07-2019 06-30-2019 10-Q
20 05-02-2019 03-31-2019 10-Q
21 03-18-2019 12-31-2018 10-K
22 11-07-2018 09-30-2018 10-Q
23 08-08-2018 06-30-2018 10-Q
24 05-09-2018 03-31-2018 10-Q
25 03-14-2018 12-31-2017 10-K
26 11-07-2017 09-30-2017 10-Q
27 08-08-2017 06-30-2017 10-Q
28 05-08-2017 03-31-2017 10-Q
29 02-27-2017 12-31-2016 10-K
30 11-09-2016 09-30-2016 10-Q
31 08-09-2016 06-30-2016 10-Q
32 05-05-2016 03-31-2016 10-Q
33 02-29-2016 12-31-2015 10-K
34 11-09-2015 09-30-2015 10-Q
35 08-10-2015 06-30-2015 10-Q
36 05-07-2015 03-31-2015 10-Q
37 02-27-2015 12-31-2014 10-K
38 11-06-2014 09-30-2014 10-Q
39 08-07-2014 06-30-2014 10-Q
40 05-08-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 novavax-in-response-to-shah-capital-says-we-welcome-the-perspectives-of-our-shareholders-and-value-their-input-on-our-strategy--believe-we-have-the-right-board-in-place-to-oversee-novavaxs-strategy

-Reuters Citing Spokesperson

 novavax-to-supply-updated-covid-19-vaccine-to-private-healthcare-providers-in-the-united-kingdom

https://ir.novavax.com/press-releases/Novavax-to-Supply-Updated-COVID-19-Vaccine-to-Private-Healthcare-Providers-in-the-United-...

 whats-going-on-with-novavax-stock-today

In a new regulatory filing, Shah Capital, which owns 9.3 million shares of Novavax representing a 6.66% stake in the company, e...

 shah-capital-nominates-two-independent-director-candidates-for-novavax

Shah Capital, which owns approximately 6.7% of the outstanding common stock of Novavax, recommends the appointment to Novavax b...

 novavax-presents-data-on-updated-covid-19-vaccine-and-progress-to-date-on-its-covid-19-influenza-combination-vaccine-candidate-at-world-vaccine-congress-2024

Novavax, Inc. (NASDAQ:NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, will showcase conti...

 novavax-inc-says-canada-national-advisory-committee-publishes-recommendation-for-use-of-novavaxs-nuvaxovid-xbb15-covid-19-vaccine-recommendations-state-that-nuvaxovid-xbb15-can-be-used-in-unvaccinated-or-previously-vaccinated-individuals-aged-12-years-and-older

- Reuters

 novavax-says-canada-national-advisory-committee-publishes-recommendation-for-use-of-novavaxs-nuvaxovid-xbb15-covid-19-vaccine-recommendations-state-that-nuvaxovid-xbb15-can-be-used-in-unvaccinated-or-previously-vaccinated-individuals-aged-12-years-and-older

- Reuters

 hc-wainwright--co-maintains-buy-on-novavax-lowers-price-target-to-19

HC Wainwright & Co. analyst Vernon Bernardino maintains Novavax (NASDAQ:NVAX) with a Buy and lowers the price target fro...

 why-bumble-shares-are-trading-lower-by-12-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results.

 why-is-covid-19-vaccine-maker-novavax-stock-plunging-on-wednesday

Novavax reports Q4 2023 revenue of $291 million, missing consensus. Restructuring brings 30% workforce reduction. Anticipates C...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION